Skip to main content

Table 1 Patient characteristics

From: Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC

 

All patients (n = 30)

Median age (y, IQR)

70 (63–73)

Sex

 

 M

26

 F

4

BCLC staging (per treatment n = 36)

 

 A

13

 B

20

 C

3

Child–Pugh (per treatment n = 36)

 

 0–1–2

2

 5

22

 6

10

 7

2

Pre-SIRT treatment received

 

 None

21

 SIRT

5

 Resection

4

 RFA

4

 TACE

2

 SABR

1

Reoccurrence location

 

 SIRT-residue

27

 None

3

 Liver, Non-SIRT

13

 Extrahepatic metastasis

3

Follow-up

 

 Alive, no recurrence

5

 Alive, with recurrence

15

 Died

10

  1. IQR interquartile range, BCLC Barcelona clinic liver cancer, SIRT selective internal radiation therapy, RFA radiofrequency ablation, TACE transarterial chemoembolization, SABR stereotactic ablative body radiotherapy